These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7940830)

  • 1. Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels.
    Alfurayh O; Sobh M; Minhas M; Almeshari K; Alshaibani K; Qunibi W; Aesha H; Taher S
    Transplant Proc; 1994 Oct; 26(5):2655. PubMed ID: 7940830
    [No Abstract]   [Full Text] [Related]  

  • 2. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.
    Kahan BD; Dunn J; Fitts C; Van Buren D; Wombolt D; Pollak R; Carson R; Alexander JW; Chang C; Choc M
    Transplant Proc; 1994 Oct; 26(5):2940-3. PubMed ID: 7940928
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
    Vathsala A; Lee WT; Jacob E; Woo KT
    Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J
    Transplant Proc; 1994 Oct; 26(5):2944-8. PubMed ID: 7940929
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of posttransplant time on dose and concentration of cyclosporine in renal transplant patients.
    Sabaté I; Santos P; Castelao AM; Martínez JM; Ruiz R; González de la Presa B; Mesado D; Palencia T; Sebastián MA; Griñó JM
    Transplant Proc; 1995 Aug; 27(4):2252-3. PubMed ID: 7652795
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.
    Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J
    Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
    Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
    Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine increases endothelin-1 plasma levels in renal transplant recipients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LE; Manfro RC
    Transplant Proc; 2004 May; 36(4):880-1. PubMed ID: 15194301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction.
    Bakr MA; Refaie A; Mekresh M; Ihab MH; Sobh M; Ghoneim MA
    Transplant Proc; 1997 Nov; 29(7):2939-40. PubMed ID: 9365621
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy.
    Odocha O; Kelly B; Trimble S; Murigande C; Toussaint RM; Callender CO
    Transplant Proc; 1996 Apr; 28(2):907-9. PubMed ID: 8623456
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 12. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
    Gross CR; Savik SK; Ascher NL; Gordon RD; Klintmalm GB; Payne W; Shaw BW; Strasburg K; Parker A; Wiesner RH
    Transplant Proc; 1994 Oct; 26(5):2686-90. PubMed ID: 7940841
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of infections in renal transplant recipients treated with cyclosporine.
    Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2658-9. PubMed ID: 7940832
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatotoxicity of cyclosporine in patients with kidney transplants].
    Karamehić J; Ascerić M; Tulumović T; Kabil E; Uzeirbegović M; Hadzibegić N
    Med Arh; 1999; 53(4):193-5. PubMed ID: 10593115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood cyclosporin A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients.
    Vernillet L; Kovarik JM; Freiburghaus R; Schaub P; Mueller EA; Niederberger W; Zehender H
    Transplant Proc; 1994 Oct; 26(5):2964-8. PubMed ID: 7940936
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2006 Dec; 38(10):3509-13. PubMed ID: 17175317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
    Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T
    Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.